Histogen Inc (NASDAQ:HSTO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past) | Director · Feb 7, 2014 – Jun 27, 2019 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past) | Director · Jul 24, 2013 – Jun 27, 2019 · Past |
| Shahzad Malik Other companies: Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 17, 2021 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Dec 6, 2018 · Past); Agenus Inc. (Director · Jun 15, 2016 – Jun 15, 2016 · Past); Aravive Inc (Director · Jun 29, 2015 – Sep 12, 2019 · Past) | Director · Jun 23, 2016 – Jun 23, 2016 · Past |
| James Scopa Other companies: Aligos Therapeutics, Inc. (Director · Since at least Apr 26, 2021); Adverum Biotechnologies Inc (Director · Since at least May 1, 2019); TriVascular Technologies Inc (Director · Apr 15, 2014 – Feb 3, 2016 · Past) | Director · Jul 24, 2013 – Jun 21, 2018 · Past |
| Kathleen Scott Other companies: ARS Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Nov 8, 2022); Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021); NKGen Biotech Inc. (Director · Sep 29, 2023 – Dec 6, 2024 · Past) | Director · Nov 18, 2019 – Nov 18, 2019 · Past |
| Richard W Pascoe Other companies: Zevra Therapeutics, Inc. (Chief Executive Officer, Director · Apr 15, 2015 – Mar 9, 2023 · Past); Apricus Biosciences Inc (CEO & Secretary, Director · Mar 18, 2013 – Jan 23, 2019 · Past); Somaxon Pharmaceuticals Inc (President and CEO, Director · Nov 28, 2008 – Dec 31, 2012 · Past) | President, CEO & Director, Director · May 26, 2020 – Mar 30, 2021 · Past |
| Susan Windham-Bannister Other companies: Humacyte, Inc. (Member of the Board, Member of Audit Committee, Member of Commercial Committee · Since at least Aug 26, 2021); Aridis Pharmaceuticals Inc. (Director · Jun 5, 2019 – Jun 27, 2024 · Past); Cambridge Bancorp (Director · Oct 17, 2017 – Jun 20, 2018 · Past) | Director · Mar 10, 2021 – Jun 20, 2023 · Past |
| Gail K. Naughton Other companies: TherapeuticsMD, Inc. (Board Member · Since at least Mar 20, 2020); Cel-Sci Corporation (Director · Aug 2, 2022 – Aug 8, 2023 · Past) | See Remarks · May 26, 2020 – Jan 13, 2021 · Past |
| William R Larue Other companies: Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Cadence Pharmaceuticals Inc (SVP, CFO, Treas, Asst Sec · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Feb 6, 2017 – Jun 27, 2019 · Past |
| Charles Cashion Other companies: Stablecoin Development Corporation (Director · Oct 24, 2007 – Jan 2, 2015 · Past) | SVP, Finance, CFO and Sec. · Jul 24, 2013 – Jan 26, 2017 · Past |
| David T Hagerty Other companies: Ardea Biosciences Inc (Senior VP & CMO · Dec 16, 2011 – Jun 19, 2012 · Past) | EVP, Clinical Development · Oct 1, 2014 – Feb 7, 2019 · Past |
| Alfred P Spada | See Remarks · Feb 1, 2023 – Feb 23, 2023 · Past |
| Brian Satz | Director · May 26, 2020 – Jun 20, 2023 · Past |
| Daniel L Ripley | SVP, Bus Dev, P&A Mgmt · Jan 26, 2017 – Feb 7, 2019 · Past |
| David Hugh Crean | Director · May 26, 2020 – Jun 20, 2023 · Past |
| Gary C Burgess | Sr. VP, Clin. Res. & CMO · Jul 24, 2013 – Feb 7, 2014 · Past |
| Jonathan Jackson | Director · May 26, 2020 – Jun 20, 2023 · Past |
| Joyce Reyes | See Remarks · Jun 1, 2022 – Mar 10, 2023 · Past |
| Marc Olivier Perret | Director · Jul 24, 2013 – Jul 30, 2013 · Past |
| Michelle L Vandertie | Vice President, Finance · Mar 31, 2017 – Aug 1, 2019 · Past |
| Moya Daniels | See Remarks · Oct 16, 2020 – Jan 13, 2021 · Past |
| Rochelle Fuhrmann | Director · Mar 25, 2021 – Jun 20, 2023 · Past |
| Stephen Chang | Director · May 26, 2020 – Oct 7, 2020 · Past |